ACADIA Pharmaceuticals-Does Acadia (ACAD) Have the Potential to Rally 27.66% as Wall Street Analysts Expect?

Acadia Pharmaceuticals (ACAD) closed the last trading session at $22.99, gaining 7.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 29.35 indicates a 27.7% upside potential.The average comprises 20 short-term price targets ranging from a low of $17.00 to a high of$ 39.00, with a standard deviation of $5.55. While the lowest estimate indicates a decline of 26.1% from the current ...